Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$120M Sell
927,567
-3,467
-0.4% -$419K 0.11% 164
2023
Q4
$106M Buy
931,034
+40,140
+5% +$4.01M 0.1% 193
2023
Q3
$81.1M Buy
890,894
+5,457
+0.6% +$563K 0.08% 243
2023
Q2
$99.7M Buy
885,437
+102,799
+13% +$10.9M 0.1% 205
2023
Q1
$81.9M Buy
782,638
+104,060
+15% +$10.9M 0.08% 241
2022
Q4
$75M Buy
678,578
+82,974
+14% +$8.7M 0.08% 262
2022
Q3
$52M Sell
595,604
-54,035
-8% -$4.91M 0.06% 356
2022
Q2
$50.8M Sell
649,639
-285,502
-31% -$23.6M 0.05% 379
2022
Q1
$79.7M Sell
935,141
-111,478
-11% -$10.7M 0.07% 307
2021
Q4
$126M Sell
1,046,619
-442,720
-30% -$54.9M 0.07% 304
2021
Q3
$184M Buy
1,489,339
+7,309
+0.5% +$941K 0.1% 192
2021
Q2
$177M Buy
1,482,030
+27,258
+2% +$3.11M 0.09% 210
2021
Q1
$153M Buy
1,454,772
+449,886
+45% +$45.6M 0.08% 278
2020
Q4
$102M Buy
1,004,886
+267,541
+36% +$25.1M 0.05% 412
2020
Q3
$62M Sell
737,345
-14,369
-2% -$1.12M 0.04% 521
2020
Q2
$48.8M Buy
751,714
+39,930
+6% +$2.64M 0.04% 551
2020
Q1
$46.4M Buy
711,784
+77,399
+12% +$6.1M 0.04% 451
2019
Q4
$50M Buy
634,385
+135,890
+27% +$10.6M 0.04% 559
2019
Q3
$39.7M Buy
498,495
+66,860
+15% +$5.25M 0.03% 563
2019
Q2
$36.1M Buy
431,635
+12,948
+3% +$1.03M 0.03% 599
2019
Q1
$33.1M Sell
418,687
-46,887
-10% -$3.42M 0.03% 598
2018
Q4
$31.1M Sell
465,574
-35,857
-7% -$2.48M 0.03% 564
2018
Q3
$40M Sell
501,431
-4,769
-0.9% -$356K 0.04% 519
2018
Q2
$34.1M Sell
506,200
-62,709
-11% -$4.55M 0.03% 551
2018
Q1
$43.8M Buy
568,909
+143,342
+34% +$10.6M 0.04% 466
2017
Q4
$29M Buy
425,567
+120,428
+39% +$8M 0.03% 673
2017
Q3
$19.1M Sell
305,139
-4,140
-1% -$247K 0.02% 861
2017
Q2
$17.1M Buy
309,279
+77,348
+33% +$4.03M 0.02% 892
2017
Q1
$11.6M Sell
231,931
-51,471
-18% -$2.51M 0.01% 1134
2016
Q4
$14M Buy
283,402
+17,788
+7% +$902K 0.01% 1010
2016
Q3
$13.9M Sell
265,614
-2,608
-1% -$128K 0.01% 1003
2016
Q2
$12M Buy
268,222
+26,548
+11% +$1.15M 0.01% 1043
2016
Q1
$9.88M Sell
241,674
-10,933
-4% -$403K 0.01% 1125
2015
Q4
$9.22M Sell
252,607
-6,102
-2% -$221K 0.01% 1196
2015
Q3
$8.5M Buy
258,709
+34,878
+16% +$1.17M 0.01% 1211
2015
Q2
$8.3M Sell
223,831
-14,211
-6% -$517K 0.01% 1378
2015
Q1
$8.34M Sell
238,042
-43,786
-16% -$1.54M 0.01% 1310
2014
Q4
$10.7M Sell
281,828
-49,699
-15% -$1.82M 0.01% 1228
2014
Q3
$11.8M Buy
331,527
+44,985
+16% +$1.67M 0.01% 1200
2014
Q2
$11.2M Sell
286,542
-63,721
-18% -$2.38M 0.01% 1314
2014
Q1
$12.8M Buy
350,263
+3,254
+0.9% +$119K 0.01% 1096
2013
Q4
$12M Sell
347,009
-3,785
-1% -$122K 0.01% 1140
2013
Q3
$9.8M Sell
350,794
-179,212
-34% -$4.78M 0.01% 1149
2013
Q2
$14.3M Buy
+530,006
New +$14.6M 0.01% 930

Other funds holding XYL

Credit Suisse's XYL Position: Q1 2024 in Review

Credit Suisse reduced its Xylem (XYL) stake by 0.37% in Q1 2024, selling an estimated $419K and leaving 927,567 shares worth $120M. The position accounts for 0.11% of the portfolio, ranked #164.

Credit Suisse first reported a position in XYL in Q2 2013 and has held it in 44 quarters since. The position peaked at $184M in Q3 2021. 987 funds tracked by Wall St. Rank hold XYL as of Q1 2024.

  • Credit Suisse held 927,567 shares of Xylem worth $120M as of Q1 2024.
  • Credit Suisse sold 3,467 Xylem shares in Q1 2024, an estimated $419K.
  • Xylem made up 0.11% of Credit Suisse's portfolio in Q1 2024, its #164 holding.
  • Credit Suisse first reported a position in Xylem in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Xylem position peaked at $184M in Q3 2021.
  • 987 funds tracked by Wall St. Rank held Xylem as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.